Scale-Up Strategies for Phase 3 Manufacturing
Planning and executing manufacturing scale-up for pivotal clinical trials.
1 min read918 viewsPublished August 15, 2025
Scale-Up Strategies for Phase 3 Manufacturing
Phase 3 Considerations
Phase 3 trials require larger quantities and more robust processes.
Scale-Up Planning
Capacity Assessment
- Volume requirements
- Timeline needs
- Commercial considerations
Process Readiness
- Process understanding
- Critical parameters defined
- Analytical methods validated
Regulatory Planning
- Site qualification
- CMC documentation
- Process validation strategy
Implementation
Batch Size Determination
- Statistical requirements
- Equipment capabilities
- Economic factors
Process Validation
- PPQ protocol design
- Sampling strategy
- Success criteria
Risk Mitigation
- Early planning
- Parallel activities
- Clear communication
- Contingency planning
Was this article helpful?
Sign in to provide feedback